Technology forges a world where human connection is no longer inhibited by distance. Barriers are broken and replaced with virtual bridges that create unprecedented potential for an interconnected present and future. And no doubt the areas most affected by this technological nexus are ones dominated by human synergy. An area at the center of this change is the pharmaceutical industry, characterized by technological and medical advancement, but faithfully guided by the necessity to improve the human condition. Clinical trials are at the forefront of pharmaceutical progress and clinical monitoring plays a key role in collecting high-quality trial data. As technology allows risk-based monitoring to become more frequently implemented, changes to the traditional monitoring set-up will occur. This report explores the reverberations of RBM implementation on trial operations as experienced by site personnel.
Sponsors & CROs